Rational Design of Peptide-Based HIV Proteinase Inhibitors-Reference-Cited by-同舟云学术

Rational Design of Peptide-Based HIV Proteinase Inhibitors

Published:1990-04-20 Issue:4953 Volume:248 Page:358-361
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Roberts Noel A.¹,Martin Joseph A.¹,Kinchington Derek²,Broadhurst Anne V.¹,Craig J. Charles¹,Duncan Ian B.¹,Galpin Sarah A.²,Handa Balraj K.¹,Kay John³,Kröhn Antonin¹,Lambert Robert W.¹,Merrett John H.¹,Mills John S.¹,Parkes Kevin E. B.¹,Redshaw Sally¹,Ritchie Alison J.¹,Taylor Debra L.⁴,Thomas Gareth J.¹,Machin Peter J.¹

Affiliation:

1. Roche Products Ltd., Hertfordshire, AL7 3AY, United Kingdom.

2. Division of Virology, Department of Medical Microbiology, St. Mary's Hospital Medical School, London WC2 1PG, United Kingdom.

3. Department of Biochemistry, University of Wales College of Cardiff, Cardiff CF1 1ST, United Kingdom.

4. Medical Research Council Collaborative Centre, London NW7 1AD, United Kingdom.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference28 articles.

1. ALLEN, M.C., RENIN INHIBITORS - SYNTHESIS OF TRANSITION-STATE ANALOG INHIBITORS CONTAINING PHOSPHORUS-ACID DERIVATIVES AT THE SCISSILE BOND, JOURNAL OF MEDICINAL CHEMISTRY 32: 1652 (1989).

2. BOGER, J, NOVEL RENIN INHIBITORS CONTAINING THE AMINO-ACID STATINE, NATURE 303: 81 (1983).

3. DANN, J.G., HUMAN RENIN - A NEW CLASS OF INHIBITORS, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 134: 71 (1986).

4. DENZIOT, F, J IMMUNOL METHODS 89: 271 (1986).

5. GRAVES, M.C., AN 11-KDA FORM OF HUMAN IMMUNODEFICIENCY VIRUS PROTEASE EXPRESSED IN ESCHERICHIA-COLI IS SUFFICIENT FOR ENZYMATIC-ACTIVITY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 2449 (1988).

Cited by 991 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

2. Affinity chromatography for virus-like particle manufacturing: Challenges, solutions, and perspectives;Journal of Chromatography A;2024-04

3. Recent Advances on Targeting Proteases for Antiviral Development;Viruses;2024-02-27

4. New drug discovery and development;Dosage Forms, Formulation Developments and Regulations;2024

5. Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement;Chemical and Pharmaceutical Bulletin;2023-12-01